vx 497 has been researched along with danoprevir in 1 studies
| Studies (vx 497) | Trials (vx 497) | Recent Studies (post-2010) (vx 497) | Studies (danoprevir) | Trials (danoprevir) | Recent Studies (post-2010) (danoprevir) |
|---|---|---|---|---|---|
| 25 | 3 | 7 | 18 | 0 | 11 |
| Protein | Taxonomy | vx 497 (IC50) | danoprevir (IC50) |
|---|---|---|---|
| Genome polyprotein | 0.0002 | ||
| Non-structural protein 4A | 0.0002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for vx 497 and danoprevir
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |